المؤلفون: Delani Woods, BS, Kylie Swiekatowski, BA, David Hopkins, MD, Yuewei Wu-Fienberg, MD

المصدر: Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 4S, Pp 75-75 (2023)

مصطلحات موضوعية: Surgery, RD1-811

وصف الملف: electronic resource

Relation: http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000934720.03373.85; https://doaj.org/toc/2169-7574

URL الوصول: https://doaj.org/article/f9c038b8819c4e1c9d4ef2cf3beac766

المؤلفون: Kaley Woods, BS, Dan Nguyen, BS, Angelia Tran, BS, Victoria Y. Yu, BS, Minsong Cao, PhD, Tianye Niu, PhD, Percy Lee, MD, Ke Sheng, PhD

المصدر: Advances in Radiation Oncology, Vol 1, Iss 1, Pp 67-75 (2016)

مصطلحات موضوعية: Medical physics. Medical radiology. Nuclear medicine, R895-920, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S245210941500010X; https://doaj.org/toc/2452-1094

URL الوصول: https://doaj.org/article/c48232555c094c4092166c084734e49c

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Woods, BS, Hawkins, NS

المصدر: In Value in Health 2009 12(3):A4-A4

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Woods BS, Hawkins N, Scott DA, Woods, Beth S, Hawkins, Neil, Scott, David A

المصدر: BMC Medical Research Methodology; 2010, Vol. 10, p54-54, 1p

المؤلفون: Woods BS; Centre for Health Economics, University of York, York, UK. Electronic address: beth.woods@york.ac.uk., Sideris E; Centre for Health Economics, University of York, York, UK., Palmer S; Centre for Health Economics, University of York, York, UK., Latimer N; School of Health and Related Research, University of Sheffield, Sheffield, UK., Soares M; Centre for Health Economics, University of York, York, UK.

المصدر: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Dec; Vol. 23 (12), pp. 1613-1621. Date of Electronic Publication: 2020 Oct 17.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

مواضيع طبية MeSH: Survival Analysis*, Antineoplastic Agents/*economics , Insurance Coverage/*organization & administration , Neoplasms/*mortality, Antineoplastic Agents/therapeutic use ; Decision Making, Organizational ; Humans ; Insurance Coverage/economics ; Insurance Coverage/statistics & numerical data ; Models, Economic ; Models, Statistical ; Neoplasms/drug therapy ; Neoplasms/economics ; Progression-Free Survival

المؤلفون: Woods BS; Centre for Health Economics, University of York, York, UK. Electronic address: beth.woods@york.ac.uk., Sideris E; Centre for Health Economics, University of York, York, UK., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Gannon MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Alzouebi M; Weston Park Hospital, Sheffield, UK., Attard G; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK., Birtle AJ; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK., Brock S; Dorset Cancer Centre, Poole Hospital NHS Foundation Trust, Poole, UK., Cathomas R; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; Kantonsspital Graubünden, Chur, Switzerland., Chakraborti PR; Royal Derby Hospital, Derby, UK., Cook A; Gloucestershire Oncology Centre, Cheltenham, UK., Cross WR; Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Dearnaley DP; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK., Gale J; Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth, UK., Gibbs S; Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Graham JD; Beacon Centre, Musgrove Park Hospital, Taunton, UK., Hughes R; Mount Vernon Group, Mount Vernon Hospital, Northwood, UK., Jones RJ; University of Glasgow, UK., Laing R; St Luke's Cancer Centre, Royal Surrey NHS Trust, Guildford, UK., Mason MD; School of Medicine, Cardiff University, Cardiff, UK., Matheson D; University of Wolverhampton, Wolverhampton, UK., McLaren DB; Department of Oncology, Western General Hospital, Edinburgh, UK., Millman R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK., Parikh O; Department of Oncology, East Lancashire Hospitals NHS Trust, Burnley, UK., Parker CC; The Royal Marsden NHS Foundation Trust, London, UK., Peedell C; South Tees NHS Foundation Trust, Middlesbrough, UK., Protheroe A; Department of Oncology, Churchill Hospital, Oxford, UK., Ritchie AWS; Gloucestershire Royal Hospital Foundation Trust, Gloucester, UK., Robinson A; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, UK., Russell JM; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; Forth Valley Royal Hospital, Larbert, UK., Simms MS; Hull and East Yorkshire Hospitals NHS Trust, Hull, UK., Srihari NN; Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK., Srinivasan R; Royal Devon & Exeter NHS Foundation Trust, Exeter, UK., Staffurth JN; Velindre Cancer Centre, Cardiff and School of Medicine, Cardiff University, Cardiff, UK., Sundar S; University of Nottingham, Nottingham, UK., Thalmann GN; Department of Urology, University Hospital Bern, Bern, Switzerland., Tolan S; Clatterbridge Cancer Centre, Birkenhead, UK., Tran ATH; The Christie NHS Foundation Trust, Manchester, UK., Tsang D; Southend and Basildon Hospitals, Southend, UK., Wagstaff J; Swansea University College of Medicine, Swansea, UK., James ND; Queen Elizabeth Hospital, Edgbaston, Birmingham, UK., Sculpher MJ; Centre for Health Economics, University of York, York, UK.

المصدر: European urology oncology [Eur Urol Oncol] 2018 Dec; Vol. 1 (6), pp. 449-458. Date of Electronic Publication: 2018 Sep 14.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cost-Benefit Analysis*, Antineoplastic Combined Chemotherapy Protocols/*economics , Prostatic Neoplasms/*drug therapy , Prostatic Neoplasms/*mortality, Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Docetaxel/administration & dosage ; Docetaxel/economics ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Prognosis ; Prostatic Neoplasms/economics ; Prostatic Neoplasms/pathology ; Quality-Adjusted Life Years ; Standard of Care ; United Kingdom